News | October 29, 2021
Laurus Labs PAT at Rs 201.90 cr. in Q2FY21
Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021
Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021
Abiraterone by Dr Reddy's becomes the first anti-cancer drug from India to enter the Chinese market
If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19
Torrent is one of India's fastest-growing pharma majors
A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
A veteran in cell therapy and oncology commercialisation
Innovative solutions and a deep understanding of the market makes this a unique combination
Arch Pharma Labs has filed the application
In addition to supporting the ongoing development of the first IND-approved product in clinical trials, the proceeds will also be used to expand the 3D printed drug product pipeline
The end user can validate the authenticity of the product by scanning the digital code with the help of a smartphone letting the end user know it is safe to use
Subscribe To Our Newsletter & Stay Updated
